Avantor (NYSE:AVTR – Get Free Report) and CarePayment Technologies (OTCMKTS:CPYT – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, dividends, analyst recommendations, institutional ownership, valuation and profitability.
Profitability
This table compares Avantor and CarePayment Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Avantor | -1.25% | 10.91% | 5.34% |
| CarePayment Technologies | N/A | N/A | N/A |
Earnings & Valuation
This table compares Avantor and CarePayment Technologies”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Avantor | $6.78 billion | 1.13 | $711.50 million | ($0.13) | -86.62 |
| CarePayment Technologies | N/A | N/A | N/A | N/A | N/A |
Avantor has higher revenue and earnings than CarePayment Technologies.
Institutional & Insider Ownership
95.1% of Avantor shares are owned by institutional investors. 1.2% of Avantor shares are owned by company insiders. Comparatively, 13.9% of CarePayment Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for Avantor and CarePayment Technologies, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Avantor | 1 | 11 | 4 | 0 | 2.19 |
| CarePayment Technologies | 0 | 0 | 0 | 0 | 0.00 |
Avantor currently has a consensus target price of $13.97, indicating a potential upside of 24.04%. Given Avantor’s stronger consensus rating and higher possible upside, research analysts clearly believe Avantor is more favorable than CarePayment Technologies.
Summary
Avantor beats CarePayment Technologies on 7 of the 9 factors compared between the two stocks.
About Avantor
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
About CarePayment Technologies
CarePayment Technologies, Inc. provides accounts receivable services in the United States. It offers services for accounts receivables generated by healthcare providers in connection with providing healthcare services to their patients under the CarePayment brand name. The company was formerly known as microHelix, Inc. CarePayment Technologies, Inc. was founded in 1991 and is based in Lake Oswego, Oregon.
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
